There was no significant difference between Arms A and B in median PFS ( 10.2 versus 8.2 months , respectively , p = 0.689 ) , objective response rate ( 65.5 % versus 53.2 % , p = 0.39 ) , and median overall survival ( 15.7 versus 14.1 months , respectively , p = 0.684 ) .